Geneventiv Therapeutics, Inc.
Raleigh, NC Doing business as Geneventiv Therapeutics Inc.
- UEI
- TJ6TFV8AN7H7
- CAGE
- 93L66
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 150 Fayetteville St #2300, Raleigh, NC 27601, USA
- Website
- geneventiv.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a universal gene therapy for hemophilia a or b with or without inhibitors - summary/abstract hemophilia… | National Heart Lung and Blood Institute | $7,581,364 |
Quick answers
What is Geneventiv Therapeutics, Inc.'s UEI?
Geneventiv Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is TJ6TFV8AN7H7.
What is Geneventiv Therapeutics, Inc.'s CAGE code?
Geneventiv Therapeutics, Inc.'s CAGE code is 93L66.
Where is Geneventiv Therapeutics, Inc. located?
Geneventiv Therapeutics, Inc.'s physical address in SAM.gov is 150 Fayetteville St #2300, Raleigh, NC 27601, USA.
Is Geneventiv Therapeutics, Inc. registered in SAM.gov?
Yes. Geneventiv Therapeutics, Inc.'s SAM.gov registration is active through June 26, 2027.
What is Geneventiv Therapeutics, Inc.'s most recent federal award?
Geneventiv Therapeutics, Inc.'s most recent federal grant award is Development of a universal gene therapy for hemophilia a or b with or without inhibitors - summary/abstract hemophilia… (R44HL174236), from National Heart Lung and Blood Institute, on April 10, 2024.
On GovTribe
See Geneventiv Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors